[Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy] (Q73685808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10769429%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

[Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10769429%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Schacht

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10769429%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10769429%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

number of pages

1 reference

Zeitschrift fuer Rheumatologie

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10769429%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

59 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10769429%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

10-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10769429%20AND%20SRC:MED&resulttype=core&format=json

Bone mineral density of the hand in rheumatoid arthritis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Rheumatoid arthritis, corticosteroid therapy and hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Generalised bone loss in patients with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Reduced bone formation in non-steroid treated patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Corticosteroid myopathy: a clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Relationship Between Disease Activity and Serum Levels of Vitamin D Metabolites and PTH in Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Muscle strength in the elderly: its relation to vitamin D metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

1,25-Dihydroxyvitamin D3 Differentially Regulates the Production of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-4 in Mouse Osteoblasts*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Rationale for active vitamin D analog therapy in senile osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Vitamin D in bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Effect of calcitriol on the secretion of prostaglandin E2, interleukin 1, and tumor necrosis factor alpha by human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Role of vitamin D in skeletal muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Immunomodulatory actions of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

The effect of 1,25(OH)2 vitamin D3 on subsets of T lymphocytes in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS003930070032

Calcium absorptive effects of vitamin D and its major metabolites

21 January 2018

1 reference

12 December 2020

Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment

1 reference

12 December 2020

Effect of 1,25(OH)2 vitamin D3 on circulating insulin-like growth factor-I and beta 2 microglobulin in patients with osteoporosis

1 reference

12 December 2020

[Generalized osteoporosis in chronic polyarthritis--pathomechanisms and treatment approaches]

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4.

1 reference

12 December 2020

Osteoporosis in rheumatoid arthritis

1 reference

12 December 2020

1,25-Dihydroxycholecalciferol Inhibits the Progression of Arthritis in Murine Models of Human Arthritis ,

1 reference

12 December 2020

Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis

1 reference

12 December 2020

Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup

1 reference

12 December 2020

Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels

1 reference

12 December 2020

Immunomodulatory effects of 1,25-dihydroxyvitamin D3.

1 reference

12 December 2020